Wiley
Wiley.com
Print this page Share
E-book

Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders, 2nd Edition

Dennis Dickson (Editor), Roy O. Weller (Editor)
ISBN: 978-1-4443-4123-2
E-book
432 pages
September 2011, Wiley-Blackwell
US $229.99 Purchase This E-book

This price is valid for United States. Change location to view local pricing and availability.

Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders, 2nd Edition (1444341235) cover image
Adobe e-books are read using Adobe Digital Editions. Install Adobe Digital Editions on your PC in order to read or transfer your e-book.
Other Available Formats: Hardcover

Most textbooks on neurodegenerative disorders have used a classification scheme based upon either clinical syndromes or anatomical distribution of the pathology.  In contrast, this book looks to the future and uses a classification based upon molecular mechanisms, rather than clinical or anatomical boundaries.  Major advances in molecular genetics and the application of biochemical and immunocytochemical techniques to neurodegenerative disorders have generated this new approach. Throughout most of the current volume, diseases are clustered according to the proteins that accumulate within cells (e.g. tau, α-synuclein and TDP-43) and in the extracellular compartments (e.g. β-amyloid and prion proteins) or according to a shared pathogenetic mechanism, such as trinucleotide repeats, that are a feature of specific genetic disorders. Chapters throughout the book conform to a standard lay-out for ease of access by the reader and are written by a panel of International Experts

Since the first edition of this book, major advances have been made in the discovery of common molecular mechanisms between many neurodegenerative diseases most notably in the frontotemporal lobar degenerations (FTLD) and motor neuron disease or amyotrophic lateral sclerosis.

This book will be essential reading for clinicians, neuropathologists and basic neuroscientists who require the firm up-to-date knowledge of mechanisms, diagnostic pathology and genetics of Neurodegenerative diseases that is required for progress in therapy and management.